Financhill
Sell
37

HCA Quote, Financials, Valuation and Earnings

Last price:
$300.82
Seasonality move :
8.19%
Day range:
$296.65 - $304.92
52-week range:
$268.01 - $417.14
Dividend yield:
0.87%
P/E ratio:
13.63x
P/S ratio:
1.16x
P/B ratio:
--
Volume:
2.9M
Avg. volume:
1.5M
1-year change:
15.24%
Market cap:
$76.9B
Revenue:
$65B
EPS (TTM):
$22.27
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $51.3B $51.5B $58.8B $60.2B $65B
Revenue Growth (YoY) 9.98% 0.38% 14.01% 2.52% 7.86%
 
Cost of Revenues $8.5B $8.4B $9.5B $9.4B $9.9B
Gross Profit $42.9B $43.2B $49.3B $50.9B $55.1B
Gross Profit Margin 83.48% 83.76% 83.86% 84.44% 84.76%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.6B $23.9B $26.8B $27.7B $29.5B
Other Inc / (Exp) -$150M -$248M $1.7B $1.3B $17M
Operating Expenses $35.6B $35.9B $39.6B $41.8B $45.4B
Operating Income $7.2B $7.3B $9.7B $9.1B $9.6B
 
Net Interest Expenses $1.8B $1.6B $1.6B $1.7B $1.9B
EBT. Incl. Unusual Items $5.2B $5.4B $9.8B $8.6B $7.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1B $1B $2.1B $1.7B $1.6B
Net Income to Company $4.1B $4.4B $7.7B $6.8B $6.1B
 
Minority Interest in Earnings -$640M -$633M -$765M -$1.2B -$849M
Net Income to Common Excl Extra Items $3.5B $3.8B $7B $5.6B $5.2B
 
Basic EPS (Cont. Ops) $10.27 $11.10 $21.52 $19.43 $19.25
Diluted EPS (Cont. Ops) $10.07 $10.93 $21.16 $19.15 $18.97
Weighted Average Basic Share $341.2M $338.3M $323.3M $290.3M $272.4M
Weighted Average Diluted Share $348.2M $343.6M $328.8M $294.7M $276.4M
 
EBITDA $9.7B $9.7B $14.3B $13.3B $12.7B
EBIT $7.1B $7B $11.4B $10.3B $9.6B
 
Revenue (Reported) $51.3B $51.5B $58.8B $60.2B $65B
Operating Income (Reported) $7.2B $7.3B $9.7B $9.1B $9.6B
Operating Income (Adjusted) $7.1B $7B $11.4B $10.3B $9.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.3B $15.3B $15B $16.2B $17.5B
Revenue Growth (YoY) 4.86% 14.76% -2% 8.3% 7.86%
 
Cost of Revenues $2.1B $2.5B $2.3B $2.4B $2.7B
Gross Profit $11.2B $12.8B $12.7B $13.8B $14.8B
Gross Profit Margin 84.01% 83.88% 84.5% 85.09% 84.81%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.1B $7.1B $6.9B $7.6B $7.9B
Other Inc / (Exp) $54M $1.1B $7M $21M $11M
Operating Expenses $9.9B $10.3B $10.5B $11.7B $12.4B
Operating Income $1.3B $2.5B $2.1B $2.1B $2.4B
 
Net Interest Expenses $385M $398M $446M $483M $515M
EBT. Incl. Unusual Items $988M $3.2B $1.7B $1.6B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $209M $685M $360M $355M $424M
Net Income to Company $779M $2.5B $1.3B $1.3B $1.5B
 
Minority Interest in Earnings -$111M -$203M -$210M -$196M -$212M
Net Income to Common Excl Extra Items $668M $2.3B $1.1B $1.1B $1.3B
 
Basic EPS (Cont. Ops) $1.97 $7.13 $3.97 $3.98 $4.94
Diluted EPS (Cont. Ops) $1.95 $7.00 $3.91 $3.91 $4.88
Weighted Average Basic Share $338.2M $318.1M $286M $271.2M $256.8M
Weighted Average Diluted Share $343.3M $324M $289.9M $275.4M $259.9M
 
EBITDA $2.1B $4.3B $2.9B $2.9B $3.3B
EBIT $1.4B $3.6B $2.2B $2.1B $2.4B
 
Revenue (Reported) $13.3B $15.3B $15B $16.2B $17.5B
Operating Income (Reported) $1.3B $2.5B $2.1B $2.1B $2.4B
Operating Income (Adjusted) $1.4B $3.6B $2.2B $2.1B $2.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $50.8B $58B $59.8B $63.2B $69.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.2B $9.4B $9.4B $9.7B $10.5B
Gross Profit $42.5B $48.5B $50.4B $53.4B $59.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.7B $26.1B $27.6B $29B $30.8B
Other Inc / (Exp) -$232M $1.1B $523M $1.3B $257M
Operating Expenses $35.7B $38.8B $41.4B $44.2B $48.6B
Operating Income $6.8B $9.7B $9B $9.2B $10.5B
 
Net Interest Expenses $1.6B $1.6B $1.7B $1.9B $2B
EBT. Incl. Unusual Items $5B $9.3B $7.9B $8.7B $8.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $999M $1.9B $1.7B $1.8B $1.9B
Net Income to Company $4B $7.4B $6.2B $6.9B $6.8B
 
Minority Interest in Earnings -$567M -$842M -$817M -$1.2B -$903M
Net Income to Common Excl Extra Items $3.4B $6.6B $5.4B $5.7B $5.9B
 
Basic EPS (Cont. Ops) $10.05 $19.96 $18.07 $20.75 $22.60
Diluted EPS (Cont. Ops) $9.89 $19.63 $17.70 $20.33 $22.27
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $9.4B $13.7B $12.5B $13.6B $14B
EBIT $6.6B $10.9B $9.6B $10.6B $10.8B
 
Revenue (Reported) $50.8B $58B $59.8B $63.2B $69.6B
Operating Income (Reported) $6.8B $9.7B $9B $9.2B $10.5B
Operating Income (Adjusted) $6.6B $10.9B $9.6B $10.6B $10.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $37.2B $43.7B $44.7B $47.7B $52.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6B $7.1B $6.9B $7.3B $8B
Gross Profit $31.2B $36.6B $37.8B $40.3B $44.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $17.5B $19.8B $20.6B $21.9B $23.3B
Other Inc / (Exp) -$253M $1.1B -$75M -$18M $222M
Operating Expenses $26.4B $29.3B $31.2B $33.5B $36.7B
Operating Income $4.8B $7.3B $6.6B $6.8B $7.7B
 
Net Interest Expenses $1.2B $1.2B $1.3B $1.4B $1.5B
EBT. Incl. Unusual Items $3.4B $7.2B $5.3B $5.4B $6.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $665M $1.5B $1.1B $1.1B $1.4B
Net Income to Company $2.7B $5.7B $4.2B $4.2B $5B
 
Minority Interest in Earnings -$365M -$574M -$626M -$595M -$649M
Net Income to Common Excl Extra Items $2.3B $5.1B $3.6B $3.6B $4.3B
 
Basic EPS (Cont. Ops) $6.89 $15.76 $12.13 $13.25 $16.55
Diluted EPS (Cont. Ops) $6.80 $15.50 $11.95 $13.05 $16.34
Weighted Average Basic Share $1B $984.4M $880.9M $822.6M $782.4M
Weighted Average Diluted Share $1B $1000M $893.3M $834.6M $792M
 
EBITDA $6.6B $10.5B $8.8B $9.1B $10.4B
EBIT $4.6B $8.4B $6.6B $6.8B $7.9B
 
Revenue (Reported) $37.2B $43.7B $44.7B $47.7B $52.3B
Operating Income (Reported) $4.8B $7.3B $6.6B $6.8B $7.7B
Operating Income (Adjusted) $4.6B $8.4B $6.6B $6.8B $7.9B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $621M $1.8B $1.5B $908M $935M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $7.4B $7.1B $8.1B $8.9B $10B
Inventory $1.8B $2B $2B $2.1B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $1.5B $2B $1.8B $2B
Total Current Assets $11.2B $12.3B $13.5B $13.6B $14.9B
 
Property Plant And Equipment $24.5B $25.2B $26.2B $27.6B $29.9B
Long-Term Investments $564M $810M $886M $1.2B $1.2B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $480M $546M $598M $298M $184M
Total Assets $45.1B $47.5B $50.7B $52.4B $56.2B
 
Accounts Payable $2.9B $3.5B $4.1B $4.2B $4.2B
Accrued Expenses $3.5B $3.7B $3.9B $3.8B $4.4B
Current Portion Of Long-Term Debt $145M $209M $237M $370M $2.4B
Current Portion Of Capital Lease Obligations $350M $379M $392M $364M $363M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $7.8B $8.7B $9.6B $9.9B $12.7B
 
Long-Term Debt $33.6B $30.8B $34.3B $37.7B $37.2B
Capital Leases -- -- -- -- --
Total Liabilities $45.6B $44.6B $49.3B $52.5B $55.2B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -- -- -$404M -$490M -$425M
Common Equity -$2.8B $572M -$933M -$2.8B -$1.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.2B $2.3B $2.4B $2.7B $2.8B
Total Equity -$565M $2.9B $1.5B -$73M $1.1B
 
Total Liabilities and Equity $45.1B $47.5B $50.7B $52.4B $56.2B
Cash and Short Terms $621M $1.8B $1.5B $908M $935M
Total Debt $33.7B $31B $34.6B $38.1B $39.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $6.6B $1B $999M $891M $2.9B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $6.4B $8.4B $8.6B $9.2B $9.9B
Inventory $2B $2B $2B $2B $1.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $1.8B $1.9B $2.2B $2.1B
Total Current Assets $16.3B $13.2B $13.5B $14.3B $16.7B
 
Property Plant And Equipment $24.9B $25.6B $27.1B $29.2B $31.2B
Long-Term Investments $725M $830M $816M $1.1B $1.3B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $542M $685M $461M $200M $309M
Total Assets $51B $49.6B $51.5B $54.6B $59.5B
 
Accounts Payable $3.3B $3.8B $4.2B $4.1B $4.2B
Accrued Expenses $4.8B $5.6B $5.4B $5.7B $6B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $6.1B -- -- -- --
Total Current Liabilities $14.4B $9.6B $9.8B $12.4B $14.9B
 
Long-Term Debt $30.8B $32B $37.5B $36.8B $38.3B
Capital Leases -- -- -- -- --
Total Liabilities $49.7B $47.7B $52.3B $54.2B $58.7B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -- -- -- -$491M -$378M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.3B $2.5B $2.6B $2.8B $3B
Total Equity $1.3B $1.8B -$778M $357M $786M
 
Total Liabilities and Equity $51B $49.6B $51.5B $54.6B $59.5B
Cash and Short Terms $6.6B $1B $999M $891M $2.9B
Total Debt $31B $32.3B $37.7B $39.3B $43B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $4.1B $4.4B $7.7B $6.8B $6.1B
Depreciation & Amoritzation $2.6B $2.7B $2.9B $3B $3.1B
Stock-Based Compensation $347M $362M $440M $341M $262M
Change in Accounts Receivable -$326M $327M -$962M -$797M -$935M
Change in Inventories -$158M -$304M -$540M -$59M -$126M
Cash From Operations $7.6B $9.2B $9B $8.5B $9.4B
 
Capital Expenditures $4.2B $2.8B $3.6B $4.4B $4.7B
Cash Acquisitions -$1.6B -$500M $1.1B $1B -$442M
Cash From Investing -$5.7B -$3.4B -$2.6B -$3.4B -$5.3B
 
Dividends Paid (Ex Special Dividend) -$550M -$153M -$624M -$653M -$661M
Special Dividend Paid
Long-Term Debt Issued $6.5B $2.7B $4.3B $6B $3.2B
Long-Term Debt Repaid -$5.3B -$3.4B -$3.9B -$2.8B -$909M
Repurchase of Common Stock -$1B -$441M -$8.2B -$7B -$3.8B
Other Financing Activities -$757M -$866M -$1.1B -$1.3B -$917M
Cash From Financing -$1.8B -$4.7B -$6.7B -$5.7B -$4.1B
 
Beginning Cash (CF) $502M $621M $1.8B $1.5B $908M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $111M $1.2B -$339M -$523M $20M
Ending Cash (CF) $621M $1.8B $1.5B $908M $935M
 
Levered Free Cash Flow $3.4B $6.4B $5.4B $4.1B $4.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $779M $2.5B $1.3B $1.3B $1.5B
Depreciation & Amoritzation $694M $716M $749M $769M $842M
Stock-Based Compensation $81M $115M $87M $72M $76M
Change in Accounts Receivable -$285M -$745M $60M -$474M $340M
Change in Inventories $21M -$120M $515M $27M $252M
Cash From Operations $2.7B $2.3B $3B $2.5B $3.5B
 
Capital Expenditures $489M $889M $1.1B $1.1B $1.2B
Cash Acquisitions -$5M $1.6B $572M -$146M -$92M
Cash From Investing -$530M $640M -$546M -$1.3B -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -$151M -$160M -$162M -$169M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -$800M $10M $2M $3B
Long-Term Debt Repaid -$39M -$56M -$84M $337M -$927M
Repurchase of Common Stock -- -$2.3B -$698M -$1.1B -$1.8B
Other Financing Activities -$206M -$167M -$225M -$169M -$231M
Cash From Financing -$245M -$3B -$2.3B -$1.1B -$110M
 
Beginning Cash (CF) $4.6B $1.1B $858M $862M $831M
Foreign Exchange Rate Adjustment $8M -$7M -$16M -$6M $4M
Additions / Reductions $1.9B -$86M $157M $35M $2.1B
Ending Cash (CF) $6.6B $1B $999M $891M $2.9B
 
Levered Free Cash Flow $2.2B $1.4B $1.9B $1.3B $2.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4B $7.4B $6.2B $6.9B $6.8B
Depreciation & Amoritzation $2.8B $2.8B $2.9B $3B $3.2B
Stock-Based Compensation $313M $474M $357M $288M $332M
Change in Accounts Receivable $697M -$1.9B -$137M -$478M -$712M
Change in Inventories -$99M -$601M -$154M -$386M $332M
Cash From Operations $15.3B $2.9B $8.4B $9.3B $10.6B
 
Capital Expenditures $3.4B $3.1B $4.3B $4.9B $4.7B
Cash Acquisitions -$390M $1.3B $39M $439M -$256M
Cash From Investing -$3.8B -$1.8B -$4.3B -$4.5B -$5.2B
 
Dividends Paid (Ex Special Dividend) -$289M -$476M -$645M -$657M -$685M
Special Dividend Paid
Long-Term Debt Issued $2.7B $4.3B $6B $3.2B $7.5B
Long-Term Debt Repaid -$3.4B -$3.8B -$2.9B -$2.2B -$3B
Repurchase of Common Stock -$713M -$6.1B -$7.6B -$4.4B -$5.3B
Other Financing Activities -$721M -$1.1B -$1.1B -$1.2B -$976M
Cash From Financing -$5.5B -$6.7B -$4.1B -$4.9B -$3.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $6B -$5.6B $4M -$122M $2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $12B -$200M $4.2B $4.4B $5.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.7B $5.7B $4.2B $4.2B $5B
Depreciation & Amoritzation $2.1B $2.1B $2.2B $2.3B $2.5B
Stock-Based Compensation $229M $341M $258M $205M $275M
Change in Accounts Receivable $930M -$1.3B -$487M -$168M $55M
Change in Inventories -$36M -$333M $53M -$274M $184M
Cash From Operations $12.8B $6.5B $6B $6.8B $8B
 
Capital Expenditures $2.1B $2.4B $3.1B $3.6B $3.6B
Cash Acquisitions -$312M $1.5B $476M -$98M $88M
Cash From Investing -$2.5B -$929M -$2.6B -$3.7B -$3.6B
 
Dividends Paid (Ex Special Dividend) -$153M -$476M -$497M -$501M -$525M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.7B $4.3B $6B $3.2B $7.5B
Long-Term Debt Repaid -$3.4B -$3.8B -$2.8B -$2.1B -$4.2B
Repurchase of Common Stock -$441M -$6.1B -$5.5B -$2.9B -$4.3B
Other Financing Activities -$584M -$780M -$812M -$762M -$821M
Cash From Financing -$4.4B -$6.3B -$3.8B -$3.1B -$2.4B
 
Beginning Cash (CF) $6B $3.9B $4.7B $2.6B $3.1B
Foreign Exchange Rate Adjustment -$4M -$4M -$33M $1M $4M
Additions / Reductions $6B -$762M -$419M -$18M $1.9B
Ending Cash (CF) $12B $3.2B $4.2B $2.6B $5B
 
Levered Free Cash Flow $10.7B $4.1B $2.9B $3.2B $4.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.8% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.65% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock